Relationship between cancer and oral pemphigoid patients with antibodies to α6-integrin

Journal of Oral Pathology and Medicine

Volumn 36, Issue 1, 2007, Pages 1-5

  Malik, Mohsin ^a,b   Gürcan, Hakan M ^a,b   Christen, William ^c   Razzaque Ahmed, A ^a,b  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anti 6 integrin (alpha6 integrin) antibody; Cancer; Mucous membrane pemphigoid; Oral pemphigoid; Relative risk

Indexed keywords

ALPHA6 INTEGRIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; SEX RATIO;

ADULT; AGE FACTORS; AGED; AUTOANTIBODIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTEGRIN ALPHA6; MALE; MIDDLE AGED; MOUTH DISEASES; NEOPLASMS; PEMPHIGOID, BULLOUS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SEX FACTORS;

EID: 33845809100     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00483.x     Document Type: Article

References (39)

1. Fleming TE, Korman NJ. Cicatricial pemphigoid. J Am Acad Dermatol 2000; 43: 571-91.
2. Dabelsteen E, Ullman S, Thomsen K, Rygaard J. Demonstration of basement membrane autoantibodies in patients with benign mucous membrane pemphigoid. Acta Derm Venereol 1974; 54: 189-92.
3. Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR. Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 2001; 80: 11-5.
4. Egan CA, Lazarova Z, Darling TN, Yee C, Cote T, Yancey KB. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 2001; 357: 1850-1.
5. Chung J, Mercurio AM. Contributions of the alpha6 integrins to breast carcinoma survival and progression. Mol Cells 2004; 17: 203-9.
6. Patriarca C, Ivanyi D, Fles D, et al. Distribution of extracellular and cytoplasmic domains of the alpha 3 and alpha 6 integrin subunits in solid tumors. Int J Cancer 1995; 63: 182-9.
7. Rabinovitz I, Nagle RB, Cress AE. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo. Clin Exp Metastasis 1995; 13: 481-91.
8. Tanaka Y, Mimori K, Shiraishi T, et al. alpha6 integrin expression in esophageal carcinoma. Int J Oncol 2000; 16: 725-9.
9. Mukhopadhyay R, Theriault RL, Price JE. Increased levels of alphaó integrins are associated with the metastatic phenotype of human breast cancer cells. Clin Exp Metastasis 1999; 17: 325-32.
10. Friedrichs K, Ruiz P, Franke F, Gille I, Terpe HJ, Imhof BA. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995; 55: 1-6.
11. Koike N, Todoroki T, Komano H, et al. Invasive potentials of gastric carcinoma cell lines: role of alpha 2 and alpha 6 integrins in invasion. J Cancer Res Clin Oncol 1997; 123: 310-6.
12. Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988; 118: 31-40.
13. Mobini N, Nagarwalla N, Ahmed AR. Oral pemphigoid. Subset of cicatricial pemphigoid? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 37-43.
14. Sami N, Bhol KC, Ahmed AR. Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titers to human alpha6 integrin. Clin Exp Immunol 2002; 129: 533-40.
15. National Cancer Institute. About SEER. (2005). Available at: http://seer.cancer.gov/about/. [Last accessed: October 24, 2005].
16. Rosner B. Fundamentals of Biostatistics: PWS-Kent Publishing Company, Boston, 1990; 90-3.
17. Megahed M. Histopathology of blistering diseases: with clinical, electron microscopic, immunological and molecular biological correlations. Heidelberg: Springer-Verlag, 2004; 183.
18. Katayama M, Sekiguchi K. Laminin-5 in epithelial tumour invasion. J Mol Histol 2004; 35: 277-86.
19. INK4A and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol 2003; 163: 477-91.
20. INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression. J Investig Dermatol Symp Proc 2005; 10: 72-85.
21. Akimoto S, Nakanishi Y, Sakamoto M, Kanai Y, Hirohashi S. Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells. Pathol Int 2004; 54: 688-92.
22. Calaluce R, Bearss DJ, Banera J, et al. Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 2004; 6: 468-79.
23. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001; 94: 763-7.
24. Pyke C, Salo S, Rallkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995; 55: 132-9.
25. Skyldberg B, Salo S, Eriksson E, et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999; 91: 1882-7.
26. Sordat I, Bosman FT, Dorta G, et al. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 1998; 185: 44-52.
27. Soini Y, Maatta M, Salo S, Tryggvason K, Autio-Harmainen H. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma. J Pathol 1996; 180: 290-4.
28. Kainulainen T, Autio-Harmainen H, Oikarinen A, Salo S, Tryggvason K, Salo T. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol 1997; 136: 1-6.
29. Hao J, Yang Y, McDaniel 1CM, Dalkin BL, Cress AE, Nagle RB. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol 1996; 149: 1341-9.
30. Taniuchi K, Takata M, Matsui C, et al. Antiepiligrin (laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5. Br J Dermatol 1999; 140: 696-700.
31. Gibson GE, Daoud MS, Pittelkow MR. Anti-epiligrin (laminin 5) cicatricial pemphigoid and lung carcinoma: coincidence or association? Br J Dermatol 1997; 137: 780-2.
32. Lenz P, Hsu R, Yee C, Yancey K, et al. Cicatricial pemphigoid with autoantibodies to laminin 5 (epiligrin) in a patient with metastatic endometrial carcinoma. Hautarzt 1998; 49: 31-S. (Abstract).
33. Thorup AK, Reibel J, Schiodt M, et al. Can alterations in integrin and laminin-5 expression be used as markers of malignancy? APMIS 1998; 106: 1170-80.
34. Franchi A, Santoro R, Paglierani M, Bondi R. Comparison of integrin alpha chain expression in benign and malignant salivary gland tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 588-95.
35. Ruiz P, Dunon D, Sonnenberg A, Imhof BA. Suppression of mouse melanoma metastasis by ea-1, a monoclonalantibody specific for alpha(6)-integrins. Cell Adhes Commun 1993; 1: 67-81.
36. Kitayama J, Nagawa H, Tsuno N, et al. Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow. Br J Cancer 1999; 80: 1927-34.
37. Dedhar S, Saulnier R. Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol 1990; 110: 481-9.
38. Ramos DM, Cheng YF, Kramer RH. Role of laminin-binding integrin in the invasion of basement membrane matrices by fibroblast cells. Invasion Metastasis 1991; 11: 125-38.
39. Bagan J, Lo Muzio L, Scully C. Mucosal disease series. Number III. Mucous membrane pemphigoid. Oral Dis 2005; 11: 197-218.